Showing results (181-190 of 195) with videos related to
Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast CancerJoanne L Blum, A Douglas Laird, Jennifer K Litton, et al.Breast Cancer (Tokyo, Japan)|June 13, 2024
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational statusMelinda L Telli, Jennifer K Litton, J Thaddeus Beck, et al.NPJ Breast Cancer|October 6, 2023
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO studyNicholas C Turner, A Douglas Laird, Melinda L Telli, et al.European Urology Oncology|October 31, 2025
Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations-Genomic Features Associated with Response to TherapyKarim Fizazi, Johann S de Bono, A Douglas Laird, et al.Nature Communications|September 24, 2017
Mitochondrial mutations drive prostate cancer aggressionJulia F Hopkins, Veronica Y Sabelnykova, Joachim Weischenfeldt, et al.JCO Precision Oncology|January 9, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural VariationsEmily L Hoskins, Eric Samorodnitsky, Michele R Wing, et al.Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.Immunity|April 28, 2022
Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis controlHannah P Gideon, Travis K Hughes, Constantine N Tzouanas, et al.Phytokeys|June 24, 2024
Advances in Legume Systematics 14. Classification of Caesalpinioideae. Part 2: Higher-level classificationAnne Bruneau, Luciano Paganucci de Queiroz, Jens J Ringelberg, et al.Nature|January 10, 2017
Genomic hallmarks of localized, non-indolent prostate cancerMichael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, et al.Pageof 20